TELMISARTAN AND HYDROCHLOROTHIAZIDE
Generic: TELMISARTAN AND HYDROCHLOROTHIAZIDE
Solco Healthcare LLCManufacturer
ORALRoute
TELMISARTANActive Substance
2017-11-06Original Approval
TELMISARTAN AND HYDROCHLOROTHIAZIDE is FDA application ANDA209028, sponsored by PRINSTON INC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2022-06-29
Telmisartan and Hydrochlorothiazide Tablets USP, 80 mg/25 mg, 30 Tablets, Rx Only, Manufactured by: Glenmark PharmaceutiDefective Container: Recall of these batches has been initiated due to complaints of difficult to o
Class II2022-06-29
Telmisartan and Hydrochlorothiazide Tablets USP, 80 mg/12.5 mg, 30 Tablets, Rx Only, Manufactured by: Glenmark PharmaceuDefective Container: Recall of these batches has been initiated due to complaints of difficult to o
Top Reported Reactions
1
DIARRHOEA
23 reports
2
DRUG INEFFECTIVE
21 reports
3
NAUSEA
21 reports
4
HYPOTENSION
20 reports
5
DIZZINESS
18 reports
6
VOMITING
17 reports
7
ASTHENIA
15 reports
8
DYSPNOEA
15 reports
9
FATIGUE
15 reports
10
HEADACHE
15 reports